The Action aims at (1) investigating the scientific, engineering and clinical issues that have been identified as the key challenges in addressing the problem of DAI; (2) finding dedicated solutions for the unmet needs in the translational process to applications (points (a)-(e) above); (3) identifying novel designed biomaterials/surfaces with enhanced antimicrobial device functionality and improved long- term stability; (4) documentation of comprehensive sets of standard and novel test methods with appropriate reference materials allowing for comparison of outcomes; (5) establishment of structure/property/function relationships and correlations between in vitro and in vivo data and (6) providing dedicated and integrated training programs across the technical disciplines and socioeconomic aspects of the field.
medical device associated infection - biomaterials - prevention of infection - biofilm - test methods
